Notable Labs (NTBL) has shared an announcement.
Notable Labs, Ltd. has undergone a significant management shift with Dr. Thomas A. Bock stepping down as Director and CEO, and the appointment of Dr. Joseph Wagner, the Chief Scientific Officer, as the interim CEO. Dr. Bock’s departure is amicable, with no disagreements reported, and he will continue as a consultant for the company. Dr. Wagner, with over two decades of experience in the biotech industry and a strong background in drug development and diagnostics, steps in during the search for a permanent CEO, bringing his extensive scientific and leadership expertise to the role.
Learn more about NTBL stock on TipRanks’ Stock Analysis page.
